Research misconduct case studies, read across institutions and years rather than one scandal at a time, show a repeatable pattern: a three-stage process (assessment, inquiry/investigation, appeal), a civil “preponderance of the evidence” standard rather than criminal proof, and appeal routes that vary sharply between the United States, the United Kingdom, and the European Union. Benchmarking against this pattern — not against any single named case — is what lets a research integrity officer (RIO) judge whether their own procedure is fit for purpose.
A research misconduct case is formally defined, under the United States’ federal regulation for Public Health Service (PHS)-funded research, as fabrication, falsification, or plagiarism (FFP), committed intentionally, knowingly, or recklessly. This article sets aside individual identities and instead compares the procedural architecture that concluded cases reveal, so integrity officers and research administration teams can stress-test their own workflow against a documented, cross-jurisdictional standard. Related terminology is catalogued in the CASRAI research administration dictionary.
- What the three-stage investigation process reveals
- What standard of proof applies in research misconduct cases
- What appeal routes exist after a misconduct finding
- How timelines and procedures compare across jurisdictions
- Frequently asked questions
- What this means for research integrity officers
What the three-stage investigation process reveals
Every concluded United States case that falls under PHS funding follows the same skeleton set out in the federal research misconduct regulation, 42 CFR Part 93. Stripped of case-specific detail, the pattern is procedural, not narrative, and it repeats regardless of discipline or seniority of the respondent.
- Assessment. The institution’s Research Integrity Officer screens the allegation to confirm it falls within the FFP definition and that the accused conducted the work under covered funding.
- Inquiry. A preliminary, fact-finding review determines whether a full investigation is warranted. Under 42 CFR §93.307, institutions are expected to complete the inquiry within 60 days of initiation, extendable only with a documented justification in the record.
- Investigation. A committee examines sequestered research records, notebooks, and raw data in full. Per 42 CFR §93.311, the Office of Research Integrity (ORI) expects institutions to complete this stage within 120 days, with the respondent given an opportunity to comment on the draft report before it is finalised.
The consistency of this three-stage architecture across decades of closed ORI case summaries is itself the diagnostic tool: cases that stall well past 60 or 120 days, or skip straight from allegation to sanction without a documented inquiry, are the ones most likely to be overturned on appeal.
What standard of proof applies in research misconduct cases
Research misconduct findings are civil, not criminal, determinations. Under 42 CFR §93.106(b), a finding requires proof by a preponderance of the evidence — that the alleged conduct is more likely than not to have occurred — rather than the “beyond reasonable doubt” threshold used in criminal law.
Three elements must all be satisfied for a finding to stand:
- The conduct represents a significant departure from accepted practices in the relevant research community.
- The act was committed intentionally, knowingly, or recklessly — honest error and legitimate differences of scientific interpretation are explicitly excluded.
- The allegation is proven by a preponderance of the evidence assembled during the inquiry and investigation stages.
This is a materially lower bar than criminal fraud statutes, which is precisely why institutions can act on data-integrity concerns years before — or entirely without — any parallel criminal or civil litigation. In the United Kingdom, no single statutory standard applies; the Concordat to Support Research Integrity, published by Universities UK, commits signatory institutions to “robust and fair” procedures but leaves the specific evidentiary threshold to each institution’s own disciplinary regulations, typically the civil “balance of probabilities” test familiar from UK employment law.
What appeal routes exist after a misconduct finding
Appeal architecture is where the US and UK systems diverge most sharply, and it is the least-benchmarked part of most institutional policies.
In the US federal system, a respondent facing a proposed debarment or suspension of federal funding eligibility can request a hearing before a Departmental Appeals Board (DAB) Administrative Law Judge, under the appeal provisions of 42 CFR Part 93, Subpart D. The ALJ hearing allows both ORI and the respondent to present evidence, and courts have previously found in favour of respondents where an agency denied a hearing without adequate justification — underscoring that procedural due process, not just the underlying evidence, is independently reviewable.
In the UK, there is no equivalent national appellate body. Appeals run through each institution’s own internal grievance or disciplinary panel, sitting outside the original investigating committee. UKRIO offers independent advisory input on request but has no statutory power to overturn or reopen a case. Where a funder, rather than an employer, makes the finding — for instance under a UKRI grant condition — the appeal route sits with the funder’s own review process, separate from the host institution’s route.
How timelines and procedures compare across jurisdictions
The table below compares the procedural pattern documented in concluded cases across the three frameworks a UK-based or internationally funded institution is most likely to encounter.
| Framework | Governing document | Recommended timeline | Standard of proof | Appeal route |
|---|---|---|---|---|
| US federal (PHS-funded) | 42 CFR Part 93 (ORI) | Inquiry: 60 days; Investigation: 120 days | Preponderance of the evidence | HHS Departmental Appeals Board ALJ hearing |
| UK institutional | Concordat to Support Research Integrity (Universities UK) | Set by each institution’s own policy; no fixed statutory deadline | Balance of probabilities (institution-defined) | Internal grievance/appeal panel; UKRIO advisory only |
| EU / Horizon Europe | European Code of Conduct for Research Integrity (ALLEA, revised 2023) | Left to national/institutional implementation | Not standardised; varies by member state | National research integrity body or institutional route, depending on country |
The gap this table exposes is one most institutional policies fail to acknowledge in writing: US regulation fixes an evidentiary standard and a timeline in federal law, while UK and EU frameworks fix principles but delegate both to the institution or member state. For an internationally funded research group, the applicable standard of proof can therefore change depending on which funder paid for the disputed work — a fact case files consistently reveal once cross-border co-authorship is involved.
Frequently asked questions
What counts as research misconduct in a case study?
Under US federal regulation and the frameworks it has influenced internationally, research misconduct is defined as fabrication, falsification, or plagiarism (FFP) committed intentionally, knowingly, or recklessly. It excludes honest error, authorship disputes, and good-faith differences in data interpretation or experimental design.
How long does a research misconduct investigation take?
Under 42 CFR Part 93, US institutions are expected to complete an inquiry within 60 days and a full investigation within 120 days of initiation. UK and EU frameworks set no equivalent statutory deadline, so timelines vary considerably by institution and case complexity.
What standard of proof is used to find research misconduct?
The applicable US standard is a preponderance of the evidence — more likely than not — rather than criminal-level proof. UK institutions typically apply the analogous civil balance of probabilities test under their own disciplinary regulations, since no single UK statutory standard exists.
Can a researcher appeal a research misconduct finding?
Yes. US respondents facing federal debarment can request a hearing before an HHS Departmental Appeals Board Administrative Law Judge. UK researchers appeal through their institution’s internal grievance or disciplinary panel, since no national appellate body for misconduct findings currently exists.
What this means for research integrity officers
Reading concluded cases for procedural pattern, rather than for scandal detail, produces a practical benchmarking checklist that any RIO can apply to their own institution’s policy:
- Does the policy document a fixed inquiry and investigation timeline, and is it consistently met in closed cases?
- Is the standard of proof — preponderance of the evidence or balance of probabilities — stated explicitly, rather than implied?
- Is the appeal route independent of the original investigating committee, with named escalation steps?
- Where research is co-funded across US, UK, or EU sources, does the policy specify which framework’s standard applies?
- Are sequestration procedures for research records triggered automatically at the inquiry stage, not the investigation stage?
Institutions that can answer all five points in writing sit closer to the documented federal pattern than those relying on ad hoc, case-by-case discretion — and case files show procedural gaps, not evidentiary weakness, are the most common ground on which findings are successfully challenged. As research increasingly crosses funder and jurisdictional boundaries, benchmarking process design against this comparative pattern, rather than against any single high-profile case, is becoming a core, auditable component of institutional research governance.